S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE...

74
STABLE CORONARY ARTERY DİSEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA AYTEK SIMSEK, M.D., Attending Physician

Transcript of S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE...

Page 1: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

STABLE CORONARY ARTERY DİSEASE

YEDITEPE UNIVERSITY FACULTY OF MEDICINE

PHASE 4 CARDIOLOGY COURSE 2014-2015

PROF. MUZAFFER DEGERTEKIN, M.D., PhD.

MUSTAFA AYTEK SIMSEK, M.D., Attending Physician

Page 2: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

ATHEROSCLEROTIC ATHEROSCLEROTIC CARDIOVASCULAR CARDIOVASCULAR

DIASEASEDIASEASE

Stable Ischemic Heart Disease

Acute Coronary Syndrome

ST-Segment Elevation Myocardial Infarction

Unstable Angina and Non–ST Elevation Myocardial Infarction

Page 3: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

DEFİNİTİONDEFİNİTİON

Coronary artery diseaseCoronary artery disease::

used to describe coronary arteries affected by a pathological process.

the narrowing of the coronary arteries or blockage of coronary blood flow, usually caused by atherosclerosis.

This can cause chest pain, shortness of breath, or myocardial infarction.

Page 4: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

NONATHEROSCLEROTİC CADNONATHEROSCLEROTİC CAD Coronary artery spasm Arteritis/vasculitis Occlusion of a coronary artery due to dissecting

aneurysm Coronary embolism Syphilitic aortitis involving the coronary ostia Cocaine induced vasospasm Vasospasm and/or thrombosis due to

hypersensitivity (Kounis syndrome) Congenital abnormalities

Page 5: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

DEFİNİTİONDEFİNİTİON

Ischemic heart dIschemic heart disease isease ((Coronary Coronary heart diseaseheart disease or atherosclerotic or atherosclerotic heart disease)heart disease)

Cardiac disease resulting from myocardial ischemia.

Although myocardial ischemia also occurs in such conditions as aortic stenosis or anemia, the term ‘ischemic heart disease’ is generally applied only to cases of atherosclerotic origin.

Page 6: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

DEFİNİTİONDEFİNİTİON ArteriosclerosisArteriosclerosis – a general term describing

any thickening and hardening of artery walls and loss of elasticity of medium or large arteries.

AtherosclerosisAtherosclerosis – process where fatty material is deposited along walls of arteries. This material thickens, hardens, and can eventually block the artery.

Atherosclerosis is just one type of arteriosclerosis

Page 7: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

2013 SCAD GUIDELINE

Page 8: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.
Page 9: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

MAGNITUDE OF THE PROBLEM

The leading cause of death The lifetime risk of developing symptomatic CAD after

age 40 (Framingham Heart Study) 49% for men 32% for women

Page 10: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.
Page 11: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

ANGINAAngina is a type of chest discomfort

caused by poor blood flow through the coronary vessels to myocardium (≥70% reduction in luminal diameter of a major coronary artery).

Page 12: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

ANGINA: EXERTIONALANGINA: EXERTIONALCoronary artery obstructions are not sufficient to

result in resting myocardial ischemia. However, when myocardial demand increases, ischemia results.

Angina:Variant AnginaAngina:Variant Angina

• Transient impairment of coronary blood supply by vasospasm or platelet aggregation

• Majority of patients have an atherosclerotic plaque

• Generalized arterial hypersensitivity• Long term prognosis very good

Page 13: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

ANGINA: SILENT ISCHEMIAANGINA: SILENT ISCHEMIA Very common More episodes of silent than painful ischemia in

the same patient No pain, but ischemic ECG changes Most common in diabetics (due to neuropathy)

Difficult to diagnose Holter monitor Exercise testing As significant as chronic SAP in terms of the subsequent

risk of ACS events, as well as mortality and morbidity.

Page 14: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

Symptoms other than angina:Breathlessness

Feeling of faintness

Anxiety

Flatulence or other dispeptic complaints

Page 15: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

ANGINA: ANGINAL EQUIVALENT ANGINA: ANGINAL EQUIVALENT SYNDROMESYNDROME

Patient’s with exertional dyspnea rather than exertional chest pain

Caused by exercise induced left ventricular dysfunction

Shortness of breath, diaphoresis

Page 16: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

EVALUATE ANGİNA PECTORİS

1. Location

2. Characteristics

3. Precipitating factors

4. Duration

5. Relieved

Page 17: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

LOCATİON Usually substernal, May extend to

the left or right chest, the shoulders, the neck, jaw, arms (usually ulnar surface of

left arm), epigastrium and the upper

back) Occasionally,the radiated

pain may be more noticeable to the patient than the origin of the pain

Page 18: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

CHARACTERİSTİCS

Deep, visceral and intense Many patients describe it as a

pressure–like, squeezing sensation

Rather than sharp or stabbing or pinprick-like pain

Page 19: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

PRECİPİTATİNG FACTORS

Exercise, heavy meal, cold weather the emotional stress Other events that obviously

increase myocardial oxygen demand, such as rapid tacharrhytmias,

extreme elevations in blood pressure,

decrease in oxygen supply such as anemia.

Page 20: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

DURATİON

Angina pectoris is transient lasting between 2 and 30 minutes.

Typically 2-10 minutes

The duration of the pain is minutes, not seconds, not hours

Chest pain that lasts longer than 30 min is more consistent with myocardial infarction, pain of less than 2 min is unlikely to be due to myocardial ischemia

Page 21: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

RELİEVED BY

cessation of the precipitating event such as exercise, or

the administration of treatment such as sublingual nitroglycerine.

Page 22: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

Angina – Types:

Typical Angina:

Atypical Angina:

Noncardiac chest pain

Stable Angina: reproducible, predictable

Unstable Angina: new onset, increased freq, intensity, duration, or occurs at rest

Page 23: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.
Page 24: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

PRE TEST PROBABILITY OF CORONARY DISEASE BY SYMPTOMS, GENDER AND AGE

Page 25: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

CCSC ANGINA CLASSIFICATIONCCSC ANGINA CLASSIFICATION

Page 26: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.
Page 27: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

PHYSİCAL EXAMİNATİONPHYSİCAL EXAMİNATİON May be completely normal

S3 or S4 may be heard

Mitral regurgitation

Blood pressure

Body mass index

Waist circumference

Page 28: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.
Page 29: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

ELECTROCARDİOGRAM ELECTROCARDİOGRAM (ECG)(ECG) All patients with suspected angina should

have a resting ECG.

May be completely normal (especially between attacks of angina)

Evidence of old myocardial infarction, bundle branch block, left ventricular hypertrophy

Page 30: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

Electrocardiogram Electrocardiogram (ECG)(ECG)• Ischemia at rest: “non-specific T and ST

changes”• changes in the T-wave or the ST segment that are “out of place”

• normally, the T-wave and the QRS complex have similar polarity

• T-wave flattening:

• T-wave inversion:

• ST-segment scooping:

•ST-segment depression:

Page 31: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

I

III

II

AVR

AVL

AVF

Inferior Ischemia in a 42 year old male at rest

Page 32: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

Anteriolateral ischemia in a 67 year old female while at rest

V1

V3

V2

V4

V6

V5

Page 33: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.
Page 34: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

LABORATORY LABORATORY EXAMİNATİONEXAMİNATİON Hemoglobin Creatinine Glucose Lipids Thyroid function High sensitive CRP Homocysteine NTproBNP Troponins

Page 35: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.
Page 36: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

CHEST X-RAYCHEST X-RAY Patients with suspected heart failure

Patients with clinical evidence of significant pulmonary disease

Page 37: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.
Page 38: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

ECHOCARDIOGRAPHYECHOCARDIOGRAPHYUsed to assess...

Myocardial Structures

– MR, TR, AR Ventricular Function

– EF

– Wall motion abnormalities Effusions

Thrombus

Ischemia

Page 39: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.
Page 40: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

SCREENING AND DIAGNOSISSCREENING AND DIAGNOSIS

StressStressTestTest

measures

measures

bloo

dbl

ood

supplysupply

to h

eart

to h

eart

CoronaryCoronaryAngiographyAngiography

spec

ific

spec

ific

showsshows

coro

nar

ies

coro

nar

ies

Narrowing inNarrowing in

Sites of

Sites of

Electro-Electro-cardiogramcardiogram

measures

measures

elec

tric

alel

ectr

ical

impulses

impulses

Page 41: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.
Page 42: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

EXERCISE STRESS TESTING EXERCISE STRESS TESTING

The most widely used

The least expensive CAD screening modality

Page 43: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

Exercise stress Exercise stress testtest• Ischemia during exercise: ST-segment

depression• usually indicative of subendocardial ischemia

• location of ischemia does not always correspond to the leads in which it is seen

J-point.08 seconds

Quantity or depth of ST-segment depression

Baseline

Page 44: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

Treadmille

Continued until The patient becomes fatigued Achieves 85% of the maximum predicted heart rate (approximately 220 minus the patient's age)

Terminated Signs or symptoms of severe ischemia (angina, ST-segment elevation, ST-segment depression >0.3 mV, or a fall in blood pressure of 10 mm Hg), arrhythmias, or heart block develop

Page 45: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

Treadmille

Page 46: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

Computer summaries can help find possible areas of ischemia – then review raw data carefully!

Determine PQ junction, J point, ST80, and estimate slope

Elevation Depression

Upsloping Horizontal Downsloping

ST SEGMENT INTERPRETATION

Page 47: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

Magnified ischemic exercise-induced ECG pattern. Three consecutive complexes with a relatively stable baseline are selected. The PQ junction (1) and J point (2) are determined; the ST 80 (3) is determined at 80 msec after the J point. In this example, average J point displacement is 0.2 mV (2 mm) and ST 80 is 0.24 mV (2.4 mm). The average slope measurement from

the J point to ST 80 is –1.1 mV/sec.

Page 48: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

Normal

Rapid Upsloping

Minor ST Depression

Slow Upsloping

Page 49: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

Horizontal

Downsloping

Elevation (non Q lead)

Elevation (Q wave lead)

Page 50: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

Duke treadmill score = duration of exercise in minutes on the Bruce protocol- (minus) 5x maximal mm ST deviation- (minus) 4x treadmill angina index

Treadmill Angina Index:0 if no angina.1 if non-limiting angina.2 if limiting angina.

High Risk = treadmill score < -1079% 4-year survivalModerate Risk = treadmill score -10 to +495% 4-year survivalLow Risk = treadmill score >+599% 4-year survival

Page 51: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

Duke Nomogram for 2 mm depression, non-limiting chest

pain at 5 METS.

Page 52: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

STRESS ELECTROCARDIOGRAPHIC STRESS ELECTROCARDIOGRAPHIC INDICATORS OF SEVERE CORONARY INDICATORS OF SEVERE CORONARY DISEASE OR POOR PROGNOSIS DISEASE OR POOR PROGNOSIS

Downsloping ST-segment depression ≥3 mV Involvement of five or more leads with ST-

segment depression Early ST-segment depression (<5 METS) Prolonged ST-segment depression late into

recovery Failure to complete stage II of Bruce protocol Failure to obtain HR >120/min (off negative

chronotropic drugs) Exertional hypotension

Page 53: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

MYOCARDIAL PERFUSION MYOCARDIAL PERFUSION IMAGING (THALLIUM SCAN)IMAGING (THALLIUM SCAN)

Used to assess... Ischemia (diagnosis and prognosis of CAD)

Ventricular Function

– Ejection Fraction Myocardial Viability

– Reversible vs non-reversible

Page 54: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

Diagnosis/prognosis for CADDiagnosis/prognosis for CAD when when Non-diagnostic EST Abnormal resting ECG Negative EST with continued chest pain Intermediate probability of disease

Defined CADDefined CAD• Post infarct risk stratification• Risk stratification to determine need

for revascularization ( viability study )

Page 55: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

STRESS STRESS ECHOECHOCARDİOGRAPHYCARDİOGRAPHY Ischemia may cause wall motion

abnormalities, no rise of fall in LVEF Sensitivity/specificity same as nuclear testing May be better in women

Page 56: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.
Page 57: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.
Page 58: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.
Page 59: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

MANAGEMENTMANAGEMENT Lifestyle modificiations

Medical Treatment

Invasive Procedures

Prevention

Page 60: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

LİFESTYLE MODİFİCİATİONSLİFESTYLE MODİFİCİATİONS Diet & salt restriction

Weight reduction

Smoking

Physical activity

Avoid precipitating factors (walking into a wind or uphill, cold weather, large meals)

Page 61: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

MEDİCAL MEDİCAL TREATMENTTREATMENT

Aspirin

ACE inhibitors

Beta-blockers

Calcium channel blockers

Nitrates

Statins

Page 62: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

TREATMENT ALGORITHMTREATMENT ALGORITHM

Page 63: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

NITRATESNITRATES

Increase in intracellular cyclic guanosine monophosphate (cGMP) levels and cause smooth muscle relaxation

Venous vasodilation/pre-load reduction Arterial dilation/after-load reduction Coronary arterial vasodilation Prevention of coronary vasoconstriction Enhancement of coronary collateral flow Antiplatelet and antithrombotic effects

Page 64: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

NITRATESNITRATES

Side EffectsHeadacheFlushingHypotension and syncope (take first dose

sitting)Palpitations Tolerance (to reduce tolerance, smaller doses

with less frequent dosing building in a nitrate-free interval of 8-12 hours and avoidance of long-acting formulations unless a prolonged nitrate-free interval is provided)

Page 65: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

StatinsStatins Reduces the risk of atherosclerotic

cardiovascular complications in both primary and secondary prevention settings.

Block cholesterol synthesis in the liver by inhibiting the enzyme 3-hydroxy-3-methyl-glutaryl coenzyme A reductase.

Atorvastatin, rosuvastatin, simvastatin, pravastatin, fluvastatin...

Not only lower cholesterol levels but also antiinflammatory and antithrombotic effects (pleiotropic effects)

Page 66: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

LİPİD LOWERİNG DRUGSLİPİD LOWERİNG DRUGS Fibrates

Reduce TG and to a lesser extent cholesterol and LDL. Nicotinic acid

Reduce TG and to a lesser extent cholesterol and LDL. increases HDL Side effects (flushing)

Bile acid sequestrants Anion exchange resins binds with cholesterol-containing bile acids in the intestine,

and promoting the conversion of cholesterol to bile acids in the liver.

Page 67: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

BETA-BLOCKERSBETA-BLOCKERS

Metoprolol, bisoprolol, propranolol, atenolol Decrease myocardial oxygen consumption Blunt exercise response, block the action of

catecholamines in increasing heart rate, blood pressure, and cardiac contractility

Try to avoid drugs with intrinsic sympathomimetic activity

First line therapy in all patients with angina if possible

Page 68: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

BETA BLOCKERS BETA BLOCKERS

Side EffectsBronchospasm Diminished exercise capacity and

fatigue Negative inotropy Sexual dysfunction Bradyarrhythmia Masking of hypoglycemia Increased claudication Hair loss

Page 69: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

CALCIUM CHANNEL BLOCKERSCALCIUM CHANNEL BLOCKERS

Verapamil, diltiazem, nifedipine, nicardipine, amlodipine, felodipine

Arterial dilation/afterload reduction Coronary arterial vasodilation Prevention of coronary vasoconstriction Enhancement of coronary collateral flow Improved subendocardial perfusion Slowing of heart rate with diltiazem, verapamil

Page 70: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

CALCIUM CHANNEL BLOCKERS CALCIUM CHANNEL BLOCKERS

Side Effects Palpitations Headache Ankle edema Gingival hyperplasia Constipation

Page 71: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.
Page 72: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

INVASİVE TREATMENT INVASİVE TREATMENT PERCUTANEOUS CORONARY INTERVENTION (PCI)

Indications for Angioplasty (+/- stenting)

Page 73: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

                                                                                                                               

                 

Page 74: S TABLE CORONARY ARTERY DISEASE YEDITEPE UNIVERSITY FACULTY OF MEDICINE PHASE 4 CARDIOLOGY COURSE 2014-2015 PROF. MUZAFFER DEGERTEKIN, M.D., PhD. MUSTAFA.

CORONARY ARTERY BYPASS GRAFT (CABG)

Indications Left main disease > 50 %

Proximal 3 vessel disease

Multivessel disease with left ventricular dysfunction

Better in diabetics

Lifestyle limiting angina unresponsive to medical therapy and/or PCI